Every Form 4 that The Hanover Insurance Group, Inc. (THG) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow THG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full THG filings page.
Hanover Insurance Group, Inc. director Joseph R. Ramrath acquired 3.7 restricted stock units on September 25, 2026, under the company’s 2022 Long-Term Incentive Plan. The grant relates to dividend equivalent rights associated with previously granted RSUs. The units vest on the earlier of the one-year anniversary of the original underlying RSUs’ grant or the next annual meeting. His reported Common Stock position following the transaction was 33,837 shares.
The Hanover Insurance Group, Inc. (THG) director Kathy S. Lane acquired 3.7 restricted stock units on September 25, 2026, under the 2022 Long-Term Incentive Plan. The award relates to dividend equivalent rights on previously granted RSUs. The units vest on the earlier of the one-year anniversary of the original underlying RSUs’ grant date or the next annual meeting, and Lane elected to defer the grant upon vesting under a deferral agreement. Her reported direct position after the award was 2,776 shares, excluding 4,829 shares held indirectly in a Rabbi Trust.
The Hanover Insurance Group, Inc. director Cynthia Egan acquired 4 shares of common stock on September 25, 2026, through a restricted stock unit grant tied to dividend equivalent rights on previously granted RSUs under the 2022 Long-Term Incentive Plan. The units vest on the earlier of the one-year anniversary of the original underlying RSUs’ grant or the next annual meeting; Egan elected to defer the grant upon vesting under a deferral agreement. Her reported direct holdings after the transaction were 10,209 shares. A footnote says this excludes 977 shares held indirectly in a Rabbi Trust under deferral agreements.
The Hanover Insurance Group, Inc. director William E. Donnell acquired 3.7 restricted stock units on September 25, 2026, as a dividend-equivalent accrual associated with previously granted RSUs under the company’s 2022 Long-Term Incentive Plan. The units vest on the earlier of the one-year anniversary of the original underlying RSUs’ grant date or the next annual meeting. Donnell’s reported direct common-stock holdings after the award were 850 shares; this excludes 977 shares held indirectly in a Rabbi Trust under deferral agreements.
Hanover Insurance Group, Inc. (THG) director J. Paul Condrin received a grant of 3.7 restricted stock units on September 25, 2026, tied to dividend equivalent rights on previously granted RSUs under the company's 2022 Long-Term Incentive Plan. His reported direct position following the transaction was 6,359.467 shares. The units vest on the earlier of the one-year anniversary of the original underlying RSUs' grant date or the next annual meeting.
Hanover Insurance Group, Inc. director Jane D. Carlin received 3.7 restricted stock units on September 25, 2026, as dividend equivalent rights associated with previously granted RSUs under the 2022 Long-Term Incentive Plan. Her reported direct common-stock position after the grant was 2,273 shares. That position excludes 2,306 shares held indirectly in a Rabbi Trust under deferral agreements.
The Hanover Insurance Group, Inc. (THG) director Theodore H. Bunting Jr. acquired 3.7 shares of common stock on September 25, 2026, through a grant of restricted stock units under the 2022 Long-Term Incentive Plan. The grant relates to accrued dividend equivalent rights on previously granted RSUs. The units vest on the earlier of the one-year anniversary of the original underlying RSUs’ grant date or the next annual meeting; his reported direct holdings afterward were 5,838.467 shares.
Hanover Insurance Group, Inc. director Kevin Bradicich received a grant of 3.7 restricted stock units on September 25, 2026, under the 2022 Long-Term Incentive Plan, in connection with dividend equivalent rights on previously granted RSUs. The units vest on the earlier of the one-year anniversary of the original RSUs’ grant date or the next annual meeting. His reported direct holdings after the transaction were 10,099 shares.
Hanover Insurance Group director Francisco Aristeguieta received a grant of 3.7 restricted stock units on September 25, 2026. The grant reflects accrued dividend equivalent rights associated with previously granted RSUs under the company’s 2022 Long-Term Incentive Plan. The units vest on the earlier of the one-year anniversary of the original underlying RSUs’ grant date or the next annual meeting. The transaction table reports 4,060 shares held directly afterward.
The Hanover Insurance Group, Inc. director Elizabeth A. Ward acquired 3.7 restricted stock units on September 25, 2026, under the company’s 2022 Long-Term Incentive Plan. The grant relates to dividend equivalent rights associated with previously granted RSUs. Her reported direct position after the transaction was 5,886.467 shares.
Hanover Insurance Group, Inc. (THG) Executive Vice President Bryan J. Salvatore reported an acquisition of 24 shares of common stock on September 25, 2026, through a grant of restricted stock units under the 2022 Long-Term Incentive Plan. The grant arose from accrued dividend equivalent rights associated with previously granted RSUs. Salvatore's reported direct common-stock holdings after the transaction were 29,118 shares.
The Hanover Insurance Group, Inc. reported that its President and CEO, John C. Roche, received a grant of 120 restricted stock units on September 25, 2026. The grant was made under the company’s 2022 Long-Term Incentive Plan in connection with dividend equivalent rights on previously granted RSUs; these RSUs vest on the third anniversary of the original underlying RSUs’ grant date. Roche’s reported direct common-stock holdings after the grant were 141,253 shares, excluding 14,454 shares held by his spouse.
The Hanover Insurance Group, Inc. (THG) reported that Patricia A. Norton-Gatto, SVP and Principal Accounting Officer, received approximately 6 restricted stock units on September 25, 2026. The award was made under the 2022 Long-Term Incentive Plan in connection with dividend equivalent rights on previously granted RSUs. Her reported direct Common Stock holdings after the transaction were approximately 2,452 shares.
The Hanover Insurance Group, Inc. (THG) Executive Vice President David John Lovely acquired 10 shares of common stock on September 25, 2026, through a restricted stock unit award tied to dividend equivalent rights on previously granted units. His reported direct common-stock holdings following the award were 3,829 shares.
Hanover Insurance Group, Inc. Executive Vice President Willard T. Lee received a grant of 10.64 restricted stock units (RSUs) on September 25, 2026. The award relates to accrued dividend equivalent rights on previously granted RSUs under the company's 2022 Long-Term Incentive Plan. The reported direct common-stock position following the award was 6,004 shares.
The Hanover Insurance Group, Inc. (THG) reported a grant of 28 restricted stock units to Executive Vice President Richard W. Lavey on September 25, 2026. The grant was made under the 2022 Long-Term Incentive Plan in connection with dividend equivalent rights on previously granted RSUs. The units vest on the third anniversary of the grant date of the original underlying RSUs; Lavey’s reported direct holdings after the transaction were 34,475 shares.
Hanover Insurance Group, Inc. (THG) Executive Vice President Dennis Francis Kerrigan received 15 restricted stock units on September 25, 2026, in a direct award tied to dividend equivalent rights on previously granted RSUs. The award is under the company’s 2022 Long-Term Incentive Plan, and the awarded RSUs vest on the third anniversary of the original underlying RSUs’ grant date. Kerrigan’s reported direct common-stock holdings after the transaction were 12,018 shares.
Hanover Insurance Group, Inc. (THG) Executive Vice President Jeffrey M. Farber acquired 42 common shares on September 25, 2026, through a grant of restricted stock units under the company’s 2022 Long-Term Incentive Plan. The grant relates to dividend equivalent rights on previously granted RSUs; these RSUs vest on the third anniversary of the original underlying RSUs’ grant date. Farber directly held 68,819 shares after the transaction.
HANOVER INSURANCE GROUP, INC. (THG) reported insider equity transactions by Executive Vice President Dennis Francis Kerrigan. On August 19–20, 2026, he exercised options to acquire a total of 8,655 shares of THG common stock at an exercise price of $118.54 per share, from an option that vested in three equal installments on February 28, 2021, 2022 and 2023. The 8,655 shares acquired upon exercise were then sold in open-market transactions on those dates at weighted-average prices around $220–$223 per share under a pre-established Rule 10b5-1 Trading Plan adopted on May 21, 2026.
Hanover Insurance Group director Theodore H. Bunting Jr. reported selling a total of 1,200 shares of common stock in two open-market or private transactions, 600 shares at $228.03 on August 5, 2026 and 600 at $230.20 on August 6, 2026. The trades were not reported under a Rule 10b5-1 trading plan.
Hanover Insurance Group, Inc. director Jane D. Carlin reported a sale of 1,000 shares of Common Stock on August 3, 2026 at $231.50 per share. After this open-market sale, she directly holds 2,269.767 shares, excluding 2,306 shares held indirectly in a Rabbi Trust under deferral agreements.
Hanover Insurance Group Executive Vice President Jeffrey M. Farber exercised stock options for 66,295 shares of common stock on July 29, 2026, at exercise prices between $115.3500 and $118.5400 per share. As part of a net exercise, the company withheld 49,330 shares to cover the exercise price and taxes, resulting in a net issuance of 16,965 shares of Hanover common stock to Farber.
LANE KATHY S reported acquisition or exercise transactions in this Form 4 filing.
Hanover Insurance Group director Kathy S. Lane reported a small equity award. She received 3.767 shares of common stock in the form of restricted stock units under the company’s 2022 Long-Term Incentive Plan, tied to dividend equivalent rights on previously granted RSUs.
After this grant, Lane holds 2,772.767 shares of common stock directly. Footnotes state the award will vest on the earlier of one year from the original RSU grant date or the next annual meeting, and that she has elected to defer the grant upon vesting under a deferral agreement. The disclosure also notes an additional 4,829 shares held indirectly in a Rabbi Trust pursuant to deferral agreements.
Hanover Insurance Group director Cynthia Egan reported a small equity award linked to prior grants. She acquired 3.767 shares of common stock through dividend-equivalent restricted stock units under the company’s 2022 Long-Term Incentive Plan. After this award, she directly holds 10,205.767 common shares, with additional shares held indirectly in a Rabbi Trust.
HANOVER INSURANCE GROUP, INC. director Jane D. Carlin reported an acquisition of common stock tied to her equity compensation. She received 3.767 restricted stock units (RSUs) on June 26, 2026 at a stated price of $0.00 per share, increasing her directly held common stock to 3,269.767 shares.
The RSUs were granted under the company’s 2022 Long-Term Incentive Plan as dividend equivalent rights on previously granted RSUs. These units vest on the earlier of the one-year anniversary of the original RSU grant date or the next annual meeting. Footnotes also note 2,306 additional shares held indirectly in a Rabbi Trust pursuant to deferral agreements.
Bunting Theodore H JR reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP, INC. director Theodore H. Bunting Jr. received a grant of 3.767 restricted stock units as a dividend equivalent under the company’s 2022 Long-Term Incentive Plan. These units vest on the earlier of the one-year anniversary of the original RSU grant or the next annual meeting, bringing his direct holdings to 7,034.767 common shares.
Donnell William E. reported acquisition or exercise transactions in this Form 4 filing.
Hanover Insurance Group director William E. Donnell reported a small equity award rather than an open-market trade. He received 3.767 restricted stock units as dividend-equivalent credits under the company’s 2022 Long-Term Incentive Plan, tied to RSUs previously granted. These units vest on the earlier of the one-year anniversary of the original RSU grant or the next annual meeting. Following this award, he holds 846.767 common shares directly, and a footnote states that a further 977 shares are held indirectly in a Rabbi Trust under deferral agreements.
Hanover Insurance Group director Kevin Bradicich received a small equity award. He was granted 3.767 shares of common stock in the form of restricted stock units connected to dividend equivalent rights under the company’s 2022 Long-Term Incentive Plan.
These units vest on the earlier of the one-year anniversary of the original RSU grant date or the date of the next annual meeting. After this award, Bradicich directly holds a total of 10,095.767 common shares. This is a routine, compensation-related acquisition rather than an open-market purchase.
Aristeguieta Francisco reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP, INC. director Francisco Aristeguieta reported a small equity compensation update. He received 3.767 shares of common stock in the form of restricted stock units granted at no cash cost under the company’s 2022 Long-Term Incentive Plan.
These RSUs were issued as dividend equivalent rights tied to previously granted RSUs and will vest on the earlier of the one-year anniversary of the original RSU grant date or the next annual meeting. Following this grant, Aristeguieta directly holds a total of 4,056.767 common shares, reflecting a routine, compensation-related accrual rather than an open-market purchase or sale.
Hanover Insurance Group director J. Paul Condrin received a small equity-based award. On June 26, 2026, he acquired 3.767 shares of common stock at $0.00 per share through a grant of restricted stock units under the company’s 2022 Long-Term Incentive Plan.
The grant reflects dividend equivalent rights tied to RSUs previously awarded under the same plan. Following this award, Condrin directly holds 6,355.767 shares of Hanover Insurance Group common stock. The new units vest on the earlier of the one-year anniversary of the original RSU grant date or the next annual meeting.
HANOVER INSURANCE GROUP, INC. director Joseph R. Ramrath received a small equity-based compensation award. He acquired 3.767 shares of Common Stock in the form of restricted stock units granted at no cash cost, tied to dividend equivalent rights on previously granted RSUs under the 2022 Long-Term Incentive Plan.
These additional units vest on the earlier of the one-year anniversary of the original RSU grant date or the next annual meeting. After this award, Ramrath directly holds a total of 33,833.767 shares of Common Stock. The transaction reflects routine compensation rather than an open-market trade.
HANOVER INSURANCE GROUP, INC. director Elizabeth A. Ward reported a small equity-based compensation grant. She acquired 3.767 shares of common stock through restricted stock units under the company’s 2022 Long-Term Incentive Plan, tied to dividend equivalent rights on previously granted RSUs. After this grant, she holds a total of 5,882.767 common shares directly. These units vest on the earlier of the one-year anniversary of the original RSU grant date or the next annual meeting.
Hanover Insurance Group Executive Vice President Salvatore J. Bryan received a small stock-based compensation award. He acquired 24.576 shares of common stock in the form of restricted stock units granted at no cash cost, tied to dividend equivalent rights on previously granted RSUs.
These RSUs were issued under Hanover’s 2022 Long-Term Incentive Plan. They will vest on the third anniversary of the grant date of the original underlying RSUs. Following this grant, Bryan directly holds 29,093.852 shares of common stock, reflecting his updated equity position.
Roche John C reported acquisition or exercise transactions in this Form 4 filing.
Hanover Insurance Group, Inc. reported that President and CEO John C. Roche received a grant of restricted stock units as part of his existing equity compensation. He was awarded 122.234 shares of common stock-equivalent RSUs under the company’s 2022 Long-Term Incentive Plan in connection with dividend equivalent rights on previously granted RSUs.
Following this award, Roche directly holds 141,132.982 shares of common stock. The filing notes that this figure does not include 14,454 additional shares held by his spouse. The newly granted RSUs will vest on the third anniversary of the original underlying RSU grant date.
HANOVER INSURANCE GROUP, INC. reported that executive Patricia A. Norton-Gatto, Senior Vice President and Principal Accounting Officer, received a small equity award in the form of restricted stock units. The grant covers 5.761 RSUs at no cash cost as a compensation-related acquisition.
These RSUs were issued under the company’s 2022 Long-Term Incentive Plan as dividend equivalent rights tied to previously granted RSUs, meaning they mirror dividends that would have been paid on earlier awards. The newly credited RSUs vest on the third anniversary of the original underlying RSU grant, and Norton-Gatto now holds 2,446.063 shares of common stock directly following this transaction.
Hanover Insurance Group Executive Vice President David John Lovely received a small equity award. On June 26, he acquired 10.612 shares of common stock in the form of restricted stock units under the 2022 Long-Term Incentive Plan, reflecting dividend equivalents on prior RSUs. These RSUs will vest on the third anniversary of the original RSU grant date, bringing his direct holdings to 3,818.533 shares.
Hanover Insurance Group Executive Vice President Willard T. Lee reported a compensation-related equity grant rather than an open-market trade. He acquired 10.833 shares of common stock in the form of restricted stock units under the company’s 2022 Long-Term Incentive Plan.
The award arises from dividend equivalent rights tied to RSUs previously granted under the same plan, and these new RSUs will vest on the third anniversary of the original RSU grant date. Following this transaction, Lee directly holds a total of 5,993.206 common shares, indicating a routine incremental increase in his equity stake.
LAVEY RICHARD W reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP, INC. Executive Vice President Richard W. Lavey received 28.415 shares of common stock as restricted stock units granted at no cost. These RSUs were credited as dividend equivalent rights tied to previously granted RSUs under the 2022 Long-Term Incentive Plan and will vest on the third anniversary of the original RSU grant date. After this award, he directly holds a total of 34,446.623 shares of common stock.
Kerrigan Dennis Francis reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP, INC. Executive Vice President Dennis Francis Kerrigan reported an automatic equity award rather than a market trade. He received 15.220 restricted stock units as dividend-equivalent RSUs under the 2022 Long-Term Incentive Plan, tied to previously granted RSUs.
These additional RSUs will vest on the third anniversary of the original RSU grant date, following the same schedule as the underlying award. After this grant, Kerrigan’s direct ownership stands at 12,002.941 shares of common stock, reflecting routine, compensation-related share accumulation.
FARBER JEFFREY M reported acquisition or exercise transactions in this Form 4 filing.
Hanover Insurance Group Executive Vice President Jeffrey M. Farber received a grant of 42.662 shares of common stock in the form of restricted stock units under the company’s 2022 Long-Term Incentive Plan. These RSUs were awarded as dividend-equivalent accruals on previously granted RSUs and vest on the third anniversary of the original RSU grant. Following this award, Farber directly holds 51,812.399 shares of common stock.
Hanover Insurance Group Executive Vice President Salvatore J. Bryan reported an option exercise and matching share sale. He exercised options for 16,394 shares of common stock at $104.11 per share, then sold 16,394 shares in open-market transactions at a weighted average price of $185.76.
The sale price reflected multiple trades between $185.38 and $186.28. Following these transactions, Bryan directly holds 29,069.276 shares of Hanover common stock, indicating his overall share count was effectively unchanged while an option position was fully exercised and eliminated.
HANOVER INSURANCE GROUP, INC. director Francisco Aristeguieta reported an open-market sale of 1,000 shares of Common Stock. The shares were sold at an average price of $195.37 per share on May 21, 2026. Following this transaction, he directly holds 4,053 shares of the company’s common stock.
Hanover Insurance Group President and CEO John C. Roche exercised stock options and then sold a portion of the resulting shares under a pre-established Rule 10b5-1 Trading Plan. On May 19, 2026, he exercised options for 33,124 shares of common stock at strike prices of $104.11 and $85.87 per share. The company withheld 24,766 shares to cover the exercise price and related taxes, resulting in a net issuance of 8,358 shares. On May 20, 2026, those 8,358 shares were sold in open-market transactions at weighted average prices around $193–$195 per share pursuant to the Rule 10b5-1 plan. After these transactions, Roche directly owns 141,010.748 shares of Hanover Insurance Group common stock, and this figure does not include 14,454 shares held by his spouse.
HANOVER INSURANCE GROUP Executive Vice President Dennis Francis Kerrigan executed an exercise-and-sell stock transaction. He exercised options to acquire 6,262 shares of Common Stock at $115.35 per share and, on the same date, sold 6,262 shares in an open-market sale at $192.99 per share.
Following these transactions, Kerrigan directly owns 11,987.721 shares of Hanover Insurance Group common stock. The exercised option covered 6,262 shares and is now fully used, with no remaining balance from that grant.
Hanover Insurance Group President and CEO John C. Roche exercised options for 18,194 shares of common stock at an exercise price of $85.87 per share. The company withheld 12,943 shares to cover the exercise price and taxes, and the remaining 5,251 shares were sold in open-market transactions at prices near $197 under a pre-established Rule 10b5-1 trading plan. Following these transactions, Roche directly holds 141,010.748 shares of Hanover common stock, not including 14,454 shares held by his spouse.
Hanover Insurance Group Executive Vice President Denise Lowsley exercised options to acquire 4,175 shares of common stock at $115.35 per share and, on the same day, sold 4,175 shares in an open-market transaction at $191.73 per share. Following these transactions, she holds 3,882.513 common shares directly.
Donnell William E. reported acquisition or exercise transactions in this Form 4 filing.
Hanover Insurance Group director William E. Donnell received an equity award of 843 shares of common stock. The shares were granted at no cash cost as restricted stock units under the company’s 2022 Long-Term Incentive Plan and will vest on the earlier of one year from the grant date or the next annual shareholder meeting. After this award, Donnell holds 843 shares directly, and a footnote notes an additional 977 shares held indirectly in a Rabbi Trust under deferral agreements.
Ward Elizabeth A reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP director Elizabeth A. Ward received an equity grant of 843 shares of common stock in the form of restricted stock units at no cost. Following this grant, she directly owns 5,879 shares. The units were granted under the 2022 Long-Term Incentive Plan and vest on the earlier of one year from grant or the next annual meeting.
LANE KATHY S reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP, INC. director Kathy S. Lane received an equity grant tied to company performance and retention. She was awarded 843 restricted stock units of common stock under the company’s 2022 Long-Term Incentive Plan at no cash cost. These units vest on the earlier of one year from the grant date or the next annual meeting, and she has elected to defer the shares upon vesting under a deferral agreement. After this award, she directly holds 2,769 common shares, and a footnote states that this does not include 4,829 additional shares held indirectly in a Rabbi Trust under separate deferral arrangements.
RAMRATH JOSEPH R reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP, INC. director Joseph R. Ramrath received a grant of 843 shares of Common Stock in the form of restricted stock units under the company’s 2022 Long-Term Incentive Plan. These units vest on the earlier of one year from grant or the next annual meeting. Following this award, he directly holds 33,830 shares.